Glucose Health, Inc. / Fundamentals
Income statement
- Net revenue
€329.54K - Cost of goods sold
€269.87K - Gross profit
€59.67K - SG&A expenses
€322.69K - R&D expenses
€4.72K - EBITDA
-€266.80K - D&A
€38.08K - EBIT
-€267.75K - Interest expenses
€8.04K - EBT
-€271.07K - Tax expenses
-€116.10K - Net income
-€271.07K
Cash flow statement
- Net deferred tax
€0.00 - Non-cash items
€49.44K - Changes in working capital
-€143.07K - Operating cash flow
-€382.49K - Capex
€15.55K - Other investing cash flow
€0.00 - Net investing cash flow
-€15.55K - Total cash dividends paid
-€15.80K - Issuance of common stock
€75.65K - Debt repayment
€189.12K - Other financing cash flow
-€0.38 - Net financing cash flow
€248.96K - Foreign exchange effects
€0.00 - Net change in cash
-€90.96K - Cash at end of period
€22.75K - Free cash flow
-€366.95K
Balance sheet
- Cash and cash equivalents
€22.75K - Cash and short-term investments
€22.75K - Total receivables
€13.63K - Inventory
€213.76K - Other current assets
€8.66K - Total current assets
€258.79K - Property, plant & equipment
€14.93K - Goodwill
€0.00 - Intangible assets
€2.83K - Long-term investments
€0.00 - Other non-current assets
€0.00 - Total non-current assets
€17.76K - Total assets
€276.55K - Accounts payable
€14.11K - Short-term debt
€201.09K - Other current liabilities
€117.12K - Total current liabilities
€332.33K - Long-term debt
€0.00 - Deferred tax liabilities
€0.00 - Other non-current liabilities
€0.00 - Total non-current liabilities
€0.00 - Total liabilities
€332.33K - Common stock
€14.64K - Retained earnings
-€7.97M - Other equity
€0.00 - Total equity
-€55.77K - Total liabilities and shareholders' equity
€276.55K
Company information
- Market capitalization
€1.18M - Employees
3 - Enterprise Value
€1.86M
Company ratios
- Gross margin
-
18.1% Even with peer group: 21.6% - EBITDA margin
-
-81.0% Much better than peer group: -680.3% - EBIT margin
-
-81.2% Much better than peer group: -686.4% - EBT margin
-
-82.3% Much better than peer group: -2,065.6% - Net margin
-
-82.3% Much better than peer group: -2,065.2% - ROE
-
486.0% Much worse than peer group: 480,706,898,483,392.3% - ROA
-
-98.0% Much better than peer group: -153,037.7% - Asset turnover
-
119.2% Much worse than peer group: 152.1% - FCF margin
-
-120.8% Much worse than peer group: -64.8% - FCF yield
-33.9% - Efficiency ratio
181.0% - Net sales per employee
-
€109.85K - Net income per employee
-
-€90.36K